ATAI Life Sciences
ATAI
ATAI
93 hedge funds and large institutions have $63.9M invested in ATAI Life Sciences in 2025 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 19 increasing their positions, 22 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
3.52% more ownership
Funds ownership: 11.04% → 14.56% (+3.5%)
14% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 22
Holders
93
Holding in Top 10
1
Calls
$1.46M
Puts
$971K
Top Buyers
| 1 | +$11.9M | |
| 2 | +$4.74M | |
| 3 | +$2.53M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$613K |
| 5 |
Goldman Sachs
New York
|
+$546K |
Top Sellers
| 1 | -$1.92M | |
| 2 | -$911K | |
| 3 | -$667K | |
| 4 |
D.E. Shaw & Co
New York
|
-$653K |
| 5 |
Citigroup
New York
|
-$282K |
